2 finantziazioak - 6.304€

2019az geroztik eskuragarri dauden datuak

2020

  1. Evaluation of the anti-CD160 antibodies in in vivo models.

    euro 5.000,00

2019

  1. Evaluation of anti-CD160 antibodies in "in vivo" models.

    euro 1.304,35